Company / Capital Returned to Shareholders
DaVita Capital Returned to Shareholders History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$1.3B
FY2025
5-year range
$1.3B / $2.4B
FY2021-FY2025
Trend
-5.6%
vs FY2024
Sector context
#13 of 108
Health Care
What the data says
DaVita's capital returned to shareholders of $1.3B is higher than 88% of companies in the Health Care sector (FY2025). Capital Returned to Shareholders has fluctuated over the past 10 years, ranging from $803M in FY2019 to $2.4B in FY2021.
Based on SEC 10-K filings.
$1.3B in FY2025 with a 5-year CAGR of +2.4%. Top quartile in the Health Care sector.
Declined from $1.5B to $1.3B over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- -3.6%
- 5-Year CAGR
- +2.4%
- 10-Year CAGR
- -
Sector benchmark
+73.3% above sector average
Key checks
Key Insights
- 5-year CAGR of +2.4%, indicating consistent growth.
- In FY2025, capital returned to shareholders decreased 5.6% year-over-year.
- Ranks #13 out of 108 companies in the Health Care sector.
- Peak capital returned to shareholders was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.3B | -5.6% |
| FY2024 | $1.4B | -9.9% |
| FY2023 | $1.5B | +5.5% |
| FY2022 | $1.5B | -38.8% |
| FY2021 | $2.4B | +105.2% |
| FY2020 | $1.2B | +44.7% |
| FY2019 | $802.9M | -26.9% |
| FY2018 | $1.1B | +36.7% |
| FY2017 | $802.9M | -26.9% |
| FY2016 | $1.1B | +99.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026